Pharmacies: how the influx of big money and technological innovation are transforming the sector
Reforms in the sector must promote innovation and market development, but they cannot ignore the impact they have on the profession
The entry of limited companies into the pharmacy sector represents one of the most significant changes of recent years and calls for reflection on the future of the pharmacy profession and the sustainability of the sector’s pension system. This is the issue I have brought to the attention of the bicameral committee responsible for overseeing the bodies that manage statutory pension schemes.
Indeed, the financial health of a pension fund can no longer be measured solely on the basis of economic and financial indicators. The sustainability of pension systems also depends on the ability of the professions to continue to attract skilled personnel, develop human capital and offer young people qualified career paths. This is a challenge that now affects all regulated professions, as demonstrated by the AppLI project promoted by the Ministry of Labour, which was set up to analyse the evolution of the professions and support labour market policies.
How the category is changing
The growth of limited companies, encouraged by recent regulatory changes, is profoundly altering the composition of the profession. The number of self-employed pharmacists is falling, whilst the number of employed pharmacists is rising, with consequences that are set to affect the sector’s pension scheme. This trend is already having tangible effects on the pension system: the number of members opting for the solidarity contribution – currently around 40,000 – and relying solely on the state pension scheme is rising. This trend raises questions not so much about the financial sustainability of the scheme, but rather about the adequacy of pension protection for future generations of pharmacists.
The influx of capital and major financial players is now a widespread phenomenon across all professions, but it also requires careful consideration of the implications for the professional autonomy of pharmacists and the relationship of trust with the public, which is one of the defining features of the Italian pharmacy sector.
The impact on regional dynamics
Added to this is a further critical issue: the concentration of investment in the most economically attractive urban areas. This trend risks widening regional disparities and makes the role of rural pharmacies even more strategic. This is why Enpaf supports these pharmacies – essential healthcare facilities in the country’s inland areas and a point of reference for thousands of citizens – by confirming an annual grant for the owners and partners of rural pharmacies, with a budget of 800,000 euros allocated for 2026.
